Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3318470
Max Phase: Preclinical
Molecular Formula: C18H13Cl2FO2S
Molecular Weight: 383.27
Molecule Type: Small molecule
Associated Items:
ID: ALA3318470
Max Phase: Preclinical
Molecular Formula: C18H13Cl2FO2S
Molecular Weight: 383.27
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1CC(c2c(F)cccc2Cl)CC(O)=C1Sc1ccccc1Cl
Standard InChI: InChI=1S/C18H13Cl2FO2S/c19-11-4-1-2-7-16(11)24-18-14(22)8-10(9-15(18)23)17-12(20)5-3-6-13(17)21/h1-7,10,22H,8-9H2
Standard InChI Key: XCZBJWBWXNJBHQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 383.27 | Molecular Weight (Monoisotopic): 381.9997 | AlogP: 6.14 | #Rotatable Bonds: 3 |
Polar Surface Area: 37.30 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.40 | CX Basic pKa: | CX LogP: 5.19 | CX LogD: 2.30 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.69 | Np Likeness Score: -0.70 |
1. Dragovich PS, Fauber BP, Boggs J, Chen J, Corson LB, Ding CZ, Eigenbrot C, Ge H, Giannetti AM, Hunsaker T, Labadie S, Li C, Liu Y, Liu Y, Ma S, Malek S, Peterson D, Pitts KE, Purkey HE, Robarge K, Salphati L, Sideris S, Ultsch M, VanderPorten E, Wang J, Wei B, Xu Q, Yen I, Yue Q, Zhang H, Zhang X, Zhou A.. (2014) Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase., 24 (16): [PMID:25037916] [10.1016/j.bmcl.2014.06.076] |
Source(1):